verified COP 4,2 · Q1 • database Scopus / SJR & Web of Science indexed

United States · John Wiley and Sons Inc

workspace_premium Q1 — Oncology visibility_off Single blind Peer Review lock_open Open Access

Cancer

Cancer is a journal indexed in SJR in Oncology and Cancer Research with an H index of 349. Journal with a Single blind Peer Review review system, and It has a price of 2500 €. The scope of the journal is focused on Cancer, Medicine, Oncology, Cancer statistics, Cancer Diagnosis. It has a COP Index of 4,2 (best band Q1). It is published in English. It has a COP Index of 4,2.

Cancer focuses its scope in these topics and keywords: cancer, patients, cell, squamous, breast, carcinoma, care, study, human, prostate, ...

ISSN: 0008-543X

Publisher: John Wiley and Sons Inc

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Visit publisher site menu_book Author guidelines

schedule CountryOfPapers database fields

COP Index trending_up

4,2 Q1

67 of 322 journals in Oncology

H-index · SJR 349 · 2,947

Acceptance rate pie_chart

17% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.500 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

COP Index

4,2

SJR Impact

2,947

H-index

349

Docs (year)

504

Docs 3y

1639

Total refs

16652

Cites 3y

7292

Citable 3y

1119

Cites/Doc 2y

4.04

Ref/Doc

33.04

Immediate OA

2500 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cell-mediated immunity to varicella zoster virus in children being treated for cancer

Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study

Detection, treatment, and outcome of isolated supraclavicular recurrence in 42 patients with invasive breast carcinoma

Cyproterone acetate--mechanism of action and clinical effectiveness in prostate cancer treatment

Correlation of bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes

Coronary artery disease mortality in patients treated for hodgkin's disease

Comparison of psychosocial adaptation and sexual function of survivors of advanced hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD

Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples

Comparative molecular analysis of loss of heterozygosity in adenocarcinoma in bile duct brushings and corresponding surgical pathology specimens

Combined antineoplastic and antiretroviral therapy for patients with hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients

Cognitive behavior therapy for people with cancer

Clinical and radiologic predictors of invasive pulmonary aspergillosis in cancer patients

SHOW MORE ARTICLES

Changes in standardized mortality rates from thyroid cancer in Korea between 1985 and 2015: Analysis of Korean national data

2-Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome

Cancer-related fatigue and its impact on functioning

Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party

Breast cancer detection among young survivors of pediatric Hodgkin lymphoma with screening magnetic resonance imaging

Author reply

Aspergillus sinusitis in cancer patients

Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus

Advance directives in the intensive care unit of a tertiary cancer center

Adenosquamous carcinoma of the pancreas

A pilot study of rituximab in patients with recurrent, classic Hodgkin disease

A Phase II study of irinotecan in patients with advanced renal cell carcinoma

FAQs

Cancer has a COP Index of 4,2 (Q1), ranked 67 of 322 in Oncology. SJR: 2,947.

Immediate OA APC is 2500 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Cancer is 17%.

Cancer

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the COP Index of Cancer?

What is the APC / publication cost?

What is the acceptance rate?